Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Purpose Detection of specific molecular alterations in tumors guides the selection of effective targeted treatment of patients with several types of cancer. These molecular alterations may occur in other tumor types for which the efficacy of targeted therapy remains unclear. The MyPathway study eval...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology Jg. 36; H. 6; S. 536
Hauptverfasser:	Hainsworth, John D, Meric-Bernstam, Funda, Swanton, Charles, Hurwitz, Herbert, Spigel, David R, Sweeney, Christopher, Burris, Howard, Bose, Ron, Yoo, Bongin, Stein, Alisha, Beattie, Mary, Kurzrock, Razelle
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 20.02.2018
Schlagworte:	Adult Aged Aged, 80 and over ErbB Receptors - antagonists & inhibitors ErbB Receptors - genetics Female Hedgehog Proteins - antagonists & inhibitors Humans Male Middle Aged Molecular Targeted Therapy - methods Mutation Neoplasms - drug therapy Neoplasms - genetics Proto-Oncogene Proteins B-raf - antagonists & inhibitors Proto-Oncogene Proteins B-raf - genetics Receptor, ErbB-2 - antagonists & inhibitors Receptor, ErbB-2 - genetics
ISSN:	1527-7755, 1527-7755
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!